Titan Spine raised US $7.5MM in Series D financing, alluded to in an earlier announcement that described the amount as “substantial.” Funds will support commercialization of a nanoLOCK surface interbody device, including a doubling of Titan’s salesforce.
In 2011, the company raised $2.6MM in Series B units from 12 investors.
Sources: Milwaukee BizTimes.com; ORTHOWORLD Inc.
Titan Spine raised US $7.5MM in Series D financing, alluded to in an earlier announcement that described the amount as "substantial." Funds will support commercialization of a nanoLOCK...
Titan Spine raised US $7.5MM in Series D financing, alluded to in an earlier announcement that described the amount as “substantial.” Funds will support commercialization of a nanoLOCK surface interbody device, including a doubling of Titan’s salesforce.
In 2011, the company raised $2.6MM in Series B units from 12 investors.
Sources: Milwaukee BizTimes.com; ORTHOWORLD Inc.
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.